Topical Medications for Diabetic Foot Ulcers
For most diabetic foot ulcers, stick to basic moisture-retentive dressings and sharp debridement—the majority of topical "advanced" therapies are not recommended and should not be used. The 2024 IWGDF guidelines strongly advise against most topical medications, with only a few conditional exceptions for specific scenarios 1.
What NOT to Use (Strong Recommendations Against)
The evidence is clear on what to avoid:
- Do not use topical antiseptic or antimicrobial dressings for wound healing (Strong recommendation, Moderate certainty) 1
- Do not use topical phenytoin despite its theoretical benefits—a 2026 RCT showed it was actually inferior to saline dressing 2
- Do not use honey or bee-related products 1
- Do not use collagen or alginate dressings 1
- Do not use herbal remedies 1
- Do not use growth factor therapy as routine adjunct (Conditional recommendation) 1—though a 2024 network meta-analysis suggested some benefit 3, guidelines remain cautious
What You CAN Consider (Conditional Recommendations)
Only use these after standard care has failed for at least 2 weeks, and only when resources exist:
Sucrose-Octasulfate Impregnated Dressing
- Consider for non-infected, neuro-ischemic ulcers that haven't responded to standard care including off-loading after 2+ weeks (Conditional, Moderate certainty) 1
- This is the most evidence-supported topical dressing option
Topical Oxygen Therapy
- Consider when standard care has failed and resources exist (Conditional, Low certainty) 1
- A 2026 case report with Granulox® showed promising results 4, supporting this conditional recommendation
Placental-Derived Products
- Consider when standard care has failed (Conditional, Low certainty) 1
- Recent 2026 network meta-analysis found these had the highest efficacy (OR 7.85) and were the only intervention to reduce adverse events 5
Autologous Leucocyte, Platelet, and Fibrin Patch
- Consider when standard care has failed and you have resources/expertise for regular venipuncture (Conditional, Moderate certainty) 1
- This is the exception to the general "no platelet therapy" rule
The Standard of Care Foundation
All adjunctive therapies require this baseline:
- Sharp debridement (frequency determined by clinical need)
- Basic moisture-retentive dressings that absorb exudate
- Appropriate off-loading
- Infection control when needed
Common Pitfalls to Avoid
- Don't jump to advanced therapies first—the guidelines emphasize these are adjunctive only after standard care fails
- Don't use topical insulin—despite a 2026 study showing benefit 6, this remains outside guideline recommendations and needs more rigorous randomized trials
- Don't confuse wound healing with infection treatment—antimicrobial dressings are specifically not recommended for wound healing, though infection management is separate
- Don't use enzymatic debridement routinely—only consider it when sharp debridement access is limited 1
Clinical Algorithm
- Start with standard care: Sharp debridement + moisture-retentive dressing + off-loading
- Assess at 2 weeks: Is there insufficient ulcer area reduction?
- If non-infected neuro-ischemic ulcer: Consider sucrose-octasulfate dressing
- If resources exist and standard care failed: Consider topical oxygen or placental-derived products
- Avoid everything else listed in the "do not use" section
The evidence base remains poor overall despite improvements, so the conservative approach prioritizing standard care is most appropriate for patient safety and outcomes.